Skip to main content
Top
Published in: European Journal of Nuclear Medicine and Molecular Imaging 12/2012

01-12-2012 | Original Article

Synthesis and characterization in monkey of [11C]SP203 as a radioligand for imaging brain metabotropic glutamate 5 receptors

Authors: Fabrice G. Siméon, Jeih-San Liow, Yi Zhang, Jinsoo Hong, Robert L. Gladding, Sami S. Zoghbi, Robert B. Innis, Victor W. Pike

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 12/2012

Login to get access

Abstract

Purpose

[18F]SP203 (3-fluoro-5-(2-(2-([18F]fluoromethyl)-thiazol-4-yl)ethynyl)benzonitrile) is an effective high-affinity and selective radioligand for imaging metabotropic 5 receptors (mGluR5) in human brain with PET. To provide a radioligand that may be used for more than one scanning session in the same subject in a single day, we set out to label SP203 with shorter-lived 11C (t 1/2 = 20.4 min) and to characterize its behavior as a radioligand with PET in the monkey.

Methods

Iodo and bromo precursors were obtained by cross-coupling 2-fluoromethyl-4-((trimethylsilyl)ethynyl)-1,3-thiazole with 3,5-diiodofluorobenzene and 3,5-dibromofluorobenzene, respectively. Treatment of either precursor with [11C]cyanide ion rapidly gave [11C]SP203, which was purified with high-performance liquid chromatography. PET was used to measure the uptake of radioactivity in brain regions after injecting [11C]SP203 intravenously into rhesus monkeys at baseline and under conditions in which mGluR5 were blocked with 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine (MTEP). The emergence of radiometabolites in monkey blood in vitro and in vivo was assessed with radio-HPLC. The stability of [11C]SP203 in human blood in vitro was also measured.

Results

The iodo precursor gave [11C]SP203 in higher radiochemical yield (>98 %) than the bromo precursor (20–52 %). After intravenous administration of [11C]SP203 into three rhesus monkeys, radioactivity peaked early in brain (average 12.5 min) with a regional distribution in rank order of expected mGluR5 density. Peak uptake was followed by a steady decline. No radioactivity accumulated in the skull. In monkeys pretreated with MTEP before [11C]SP203 administration, radioactivity uptake in brain was again high but then declined more rapidly than in the baseline scan to a common low level. [11C]SP203 was unstable in monkey blood in vitro and in vivo, and gave predominantly less lipophilic radiometabolites. By contrast, [11C]SP203 was stable in human blood in vitro.

Conclusion

[11C]SP203 emulates [18F]SP203 with regard to providing a sizeable mGluR5-specific signal in monkey brain, and advantageously avoids troublesome accumulation of radioactivity in bone. Although [11C]SP203 is unsuitable for mGluR5 quantification in monkey brain, its evaluation as a PET radioligand for studying human brain mGluR5 is nevertheless warranted.
Literature
1.
go back to reference Conn PJ, Pin J-P. Pharmacology and functions of metabotropic glutamate receptors. Annu Rev Pharmacol Toxicol. 1997;37:205–37.PubMedCrossRef Conn PJ, Pin J-P. Pharmacology and functions of metabotropic glutamate receptors. Annu Rev Pharmacol Toxicol. 1997;37:205–37.PubMedCrossRef
2.
go back to reference Zhu CZ, Wilson SG, Mikusa JP, Wismer CT, Gauvin DM, Lynch JJ, et al. Assessing the role of metabotropic glutamate receptor 5 in multiple nociceptive modalities. Eur J Pharmacol. 2004;506:107–18.PubMedCrossRef Zhu CZ, Wilson SG, Mikusa JP, Wismer CT, Gauvin DM, Lynch JJ, et al. Assessing the role of metabotropic glutamate receptor 5 in multiple nociceptive modalities. Eur J Pharmacol. 2004;506:107–18.PubMedCrossRef
3.
go back to reference Cosford NDP, Tehrani L, Roppe J, Schweiger E, Smith ND, Anderson J, et al. 3-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]-pyridine: a potent and highly selective metabotropic glutamate subtype 5 receptor antagonist with anxiolytic activity. J Med Chem. 2003;46:204–6.PubMedCrossRef Cosford NDP, Tehrani L, Roppe J, Schweiger E, Smith ND, Anderson J, et al. 3-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]-pyridine: a potent and highly selective metabotropic glutamate subtype 5 receptor antagonist with anxiolytic activity. J Med Chem. 2003;46:204–6.PubMedCrossRef
4.
go back to reference Pietraszek M, Nagel J, Gravius A, Schafer D, Danysz W. The role of group I metabotropic glutamate receptors in schizophrenia. Amino Acids. 2007;32:173–8.PubMedCrossRef Pietraszek M, Nagel J, Gravius A, Schafer D, Danysz W. The role of group I metabotropic glutamate receptors in schizophrenia. Amino Acids. 2007;32:173–8.PubMedCrossRef
5.
go back to reference Tessari M, Pilla M, Andreoli M, Hutcheson DM, Heidbreder CA. Antagonism at metabotropic glutamate 5 receptor inhibits nicotine- and cocaine-taking behaviors and prevents nicotine-triggered relapse to nicotine seeking. Eur J Pharmacol. 2004;499:121–3.PubMedCrossRef Tessari M, Pilla M, Andreoli M, Hutcheson DM, Heidbreder CA. Antagonism at metabotropic glutamate 5 receptor inhibits nicotine- and cocaine-taking behaviors and prevents nicotine-triggered relapse to nicotine seeking. Eur J Pharmacol. 2004;499:121–3.PubMedCrossRef
6.
go back to reference Chiamulera C, Epping-Jordan MP, Zocchi A, Marcon C, Cottiny C, Tacconi S, et al. Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice. Nat Neurosci. 2001;4:873–4.PubMedCrossRef Chiamulera C, Epping-Jordan MP, Zocchi A, Marcon C, Cottiny C, Tacconi S, et al. Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice. Nat Neurosci. 2001;4:873–4.PubMedCrossRef
7.
go back to reference Maccarrone M, Rossi S, Bari M, De Chiara V, Rapino C, Musella A, et al. Abnormal mGlu5 receptor/endocannabinoid coupling in mice lacking FMRP and BC1 RNA. Neuropsychopharmacology. 2010;35:1500–9.PubMedCrossRef Maccarrone M, Rossi S, Bari M, De Chiara V, Rapino C, Musella A, et al. Abnormal mGlu5 receptor/endocannabinoid coupling in mice lacking FMRP and BC1 RNA. Neuropsychopharmacology. 2010;35:1500–9.PubMedCrossRef
8.
go back to reference Gravius A, Pietraszek M, Dekundy A, Danysz W. Metabotropic glutamate receptors as therapeutic targets for cognitive disorders. Curr Topics Med Chem. 2010;10:187–206.CrossRef Gravius A, Pietraszek M, Dekundy A, Danysz W. Metabotropic glutamate receptors as therapeutic targets for cognitive disorders. Curr Topics Med Chem. 2010;10:187–206.CrossRef
9.
go back to reference Siméon FG, Brown AK, Zoghbi SS, Patterson VM, Innis RB, Pike VW. Synthesis and simple 18F-labeling of a high affinity 2-(fluoromethyl)thiazole derivative ([18F]SP203) as a radioligand for imaging brain metabotropic glutamate subtype-5 receptors with PET. J Med Chem. 2007;50:3256–66.PubMedCrossRef Siméon FG, Brown AK, Zoghbi SS, Patterson VM, Innis RB, Pike VW. Synthesis and simple 18F-labeling of a high affinity 2-(fluoromethyl)thiazole derivative ([18F]SP203) as a radioligand for imaging brain metabotropic glutamate subtype-5 receptors with PET. J Med Chem. 2007;50:3256–66.PubMedCrossRef
10.
go back to reference Brown AK, Kimura Y, Zoghbi SS, Siméon FG, Liow JS, Kreisl WC, et al. Metabotropic glutamate subtype-5 (mGluR5) receptors quantified in human brain with a novel radioligand for positron emission tomography. J Nucl Med. 2008;49:2042–8.PubMedCrossRef Brown AK, Kimura Y, Zoghbi SS, Siméon FG, Liow JS, Kreisl WC, et al. Metabotropic glutamate subtype-5 (mGluR5) receptors quantified in human brain with a novel radioligand for positron emission tomography. J Nucl Med. 2008;49:2042–8.PubMedCrossRef
11.
go back to reference Kimura Y, Siméon FG, Hatazawa J, Mozley PD, Pike VW, Innis RB, et al. Biodistribution and radiation dosimetry of a positron emission tomography ligand, 18F-SP203, to image metabotropic glutamate subtype 5 (mGluR5) receptor in humans. Eur J Nucl Med Mol Imaging. 2010;37:1943–9.PubMedCrossRef Kimura Y, Siméon FG, Hatazawa J, Mozley PD, Pike VW, Innis RB, et al. Biodistribution and radiation dosimetry of a positron emission tomography ligand, 18F-SP203, to image metabotropic glutamate subtype 5 (mGluR5) receptor in humans. Eur J Nucl Med Mol Imaging. 2010;37:1943–9.PubMedCrossRef
12.
go back to reference Kimura Y, Siméon FG, Zoghbi SS, Zhang Y, Hatazawa J, Pike VW, et al. Quantification of metabotropic glutamate receptor subtype 5 receptors in the brain by an equilibrium method using 18F-SP203. Neuroimage. 2012;59:2124–30.PubMedCrossRef Kimura Y, Siméon FG, Zoghbi SS, Zhang Y, Hatazawa J, Pike VW, et al. Quantification of metabotropic glutamate receptor subtype 5 receptors in the brain by an equilibrium method using 18F-SP203. Neuroimage. 2012;59:2124–30.PubMedCrossRef
13.
go back to reference Shetty HU, Zoghbi SS, Siméon FG, Liow JS, Brown AK, Kannan P, et al. Radiodefluorination of 3-fluoro-5-(2-(2-([18F]fluoromethyl)thiazol-4-yl)ethynyl)benzonitrile ([18F]SP203), a radioligand for imaging brain mGluR5 in vivo, occurs by glutathionylation in rat brain. J Pharmacol Exp Ther. 2008;327:727–35.PubMedCrossRef Shetty HU, Zoghbi SS, Siméon FG, Liow JS, Brown AK, Kannan P, et al. Radiodefluorination of 3-fluoro-5-(2-(2-([18F]fluoromethyl)thiazol-4-yl)ethynyl)benzonitrile ([18F]SP203), a radioligand for imaging brain mGluR5 in vivo, occurs by glutathionylation in rat brain. J Pharmacol Exp Ther. 2008;327:727–35.PubMedCrossRef
14.
go back to reference Gopinathan MB, Jin C, Rehder KS. A short and efficient synthesis of 3-{2-[2-(bromomethyl)thiazol-4-yl]ethynyl}-5-fluorobenzonitrile: a precursor for PET radioligand [18F]SP203. Synthesis Stuttgart. 2009;12:1979–82. Gopinathan MB, Jin C, Rehder KS. A short and efficient synthesis of 3-{2-[2-(bromomethyl)thiazol-4-yl]ethynyl}-5-fluorobenzonitrile: a precursor for PET radioligand [18F]SP203. Synthesis Stuttgart. 2009;12:1979–82.
15.
go back to reference Iwata R, Ido T, Takahashi T, Nakanishi H, Iida S. Optimization of [11C]HCN production and no-carrier-added [1-11C]amino acid synthesis. Appl Radial Isot. 1987;38:97–102.CrossRef Iwata R, Ido T, Takahashi T, Nakanishi H, Iida S. Optimization of [11C]HCN production and no-carrier-added [1-11C]amino acid synthesis. Appl Radial Isot. 1987;38:97–102.CrossRef
16.
go back to reference Christman DR, Finn RD, Karlström KI, Wolf AP. Production of ultra high activity 11C-labeled hydrogen-cyanide, carbon-dioxide, carbon-monoxide and methane via 14N(p, α)11C reaction. Int J Appl Radiat Isot. 1975;26:435–42.CrossRef Christman DR, Finn RD, Karlström KI, Wolf AP. Production of ultra high activity 11C-labeled hydrogen-cyanide, carbon-dioxide, carbon-monoxide and methane via 14N(p, α)11C reaction. Int J Appl Radiat Isot. 1975;26:435–42.CrossRef
17.
go back to reference Bjurling P, Reineck R, Westerberg G, Gee AD, Sutcliffe J, Långström B. Proceedings of the 6th Workshop on Targetry and Target Chemistry, TRIUMF, 1995, p. 282−284. Bjurling P, Reineck R, Westerberg G, Gee AD, Sutcliffe J, Långström B. Proceedings of the 6th Workshop on Targetry and Target Chemistry, TRIUMF, 1995, p. 282−284.
18.
go back to reference Clark J, Baldwin R, Bayne K, Brown MJ, Gebhart GF, Gonder JC, et al. Guide for the care and use of laboratory animals. Washington, DC: Institute of Laboratory Animal Resources, National Research Council; 1996. Clark J, Baldwin R, Bayne K, Brown MJ, Gebhart GF, Gonder JC, et al. Guide for the care and use of laboratory animals. Washington, DC: Institute of Laboratory Animal Resources, National Research Council; 1996.
19.
go back to reference Cosford NDP, Tehrani L, Arruda J, King C, McDonald IA, Munoz B, et al. 3-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]pyridine (MTEP): design and synthesis of a potent and highly selective metabotropic glutamate subtype 5 (mGlu5) receptor antagonist with anxiolytic activity. Neuropharmacology. 2002;43:282–3. Cosford NDP, Tehrani L, Arruda J, King C, McDonald IA, Munoz B, et al. 3-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]pyridine (MTEP): design and synthesis of a potent and highly selective metabotropic glutamate subtype 5 (mGlu5) receptor antagonist with anxiolytic activity. Neuropharmacology. 2002;43:282–3.
20.
go back to reference Yasuno F, Brown AK, Zoghbi SS, Krushinski JH, Chernet E, Tauscher J, et al. The PET radioligand [11C]MePPEP binds reversibly and with high specific signal to cannabinoid CB1 receptors in nonhuman primate brain. Neuropsychopharmacology. 2008;33:259–69.PubMedCrossRef Yasuno F, Brown AK, Zoghbi SS, Krushinski JH, Chernet E, Tauscher J, et al. The PET radioligand [11C]MePPEP binds reversibly and with high specific signal to cannabinoid CB1 receptors in nonhuman primate brain. Neuropsychopharmacology. 2008;33:259–69.PubMedCrossRef
21.
go back to reference Zoghbi SS, Shetty UH, Ichise M, Fujita M, Imaizumi M, Liow JS, et al. PET imaging of the dopamine transporter with [18F]FECNT: a polar radiometabolite confounds brain radioligand measurements. J Nucl Med. 2006;47:520–7.PubMed Zoghbi SS, Shetty UH, Ichise M, Fujita M, Imaizumi M, Liow JS, et al. PET imaging of the dopamine transporter with [18F]FECNT: a polar radiometabolite confounds brain radioligand measurements. J Nucl Med. 2006;47:520–7.PubMed
22.
go back to reference Airaksinen AJ, Andersson J, Truong P, Karlsson O, Halldin C. Radiosynthesis of [11C]ximelagatran via palladium catalyzed [11C]cyanation. J Label Compds Radiopharm. 2007;51:1–5.CrossRef Airaksinen AJ, Andersson J, Truong P, Karlsson O, Halldin C. Radiosynthesis of [11C]ximelagatran via palladium catalyzed [11C]cyanation. J Label Compds Radiopharm. 2007;51:1–5.CrossRef
23.
go back to reference Andersson J, Truong P, Halldin C. In-target produced [11C]methane: increased specific radioactivity. Appl Radiat Isot. 2009;67:106–10.PubMedCrossRef Andersson J, Truong P, Halldin C. In-target produced [11C]methane: increased specific radioactivity. Appl Radiat Isot. 2009;67:106–10.PubMedCrossRef
24.
go back to reference Hamill TG, Krause S, Ryan C, Bonnefous C, Govek S, Sieders TJ, et al. Synthesis, characterization, and first successful monkey imaging studies of metabotropic glutamate receptor subtype 5 (mGluR5) PET radiotracers. Synapse. 2005;56:205–16.PubMedCrossRef Hamill TG, Krause S, Ryan C, Bonnefous C, Govek S, Sieders TJ, et al. Synthesis, characterization, and first successful monkey imaging studies of metabotropic glutamate receptor subtype 5 (mGluR5) PET radiotracers. Synapse. 2005;56:205–16.PubMedCrossRef
25.
go back to reference Andersson Y, Långström B. Transition metal-mediated reactions using [11C]cyanide in synthesis of 11C-labeled aromatic-compounds. J Chem Soc Perkin Trans 1. 1994;11:1395–400.CrossRef Andersson Y, Långström B. Transition metal-mediated reactions using [11C]cyanide in synthesis of 11C-labeled aromatic-compounds. J Chem Soc Perkin Trans 1. 1994;11:1395–400.CrossRef
26.
go back to reference Lindsley CW, Bates BS, Menon UN, Jadhav SB, Kane AS, Jones CK, et al. (3-Cyano-5-fluorophenyl)biaryl negative allosteric modulators of mGlu5: discovery of a new tool compound with activity in the OSS mouse model of addiction. ACS Chem Neurosci. 2011;2:471–82.PubMedCrossRef Lindsley CW, Bates BS, Menon UN, Jadhav SB, Kane AS, Jones CK, et al. (3-Cyano-5-fluorophenyl)biaryl negative allosteric modulators of mGlu5: discovery of a new tool compound with activity in the OSS mouse model of addiction. ACS Chem Neurosci. 2011;2:471–82.PubMedCrossRef
27.
go back to reference Zoghbi SS, Anderson KB, Jenko KJ, Luckenbaugh DA, Innis RB, Pike VW. On quantitative relationships between drug-like compound lipophilicity and plasma free fraction in monkey and human. J Pharm Sci. 2012;101:1028–39.PubMedCrossRef Zoghbi SS, Anderson KB, Jenko KJ, Luckenbaugh DA, Innis RB, Pike VW. On quantitative relationships between drug-like compound lipophilicity and plasma free fraction in monkey and human. J Pharm Sci. 2012;101:1028–39.PubMedCrossRef
28.
go back to reference Okamura T, Kikuchi T, Okada M, Toramatsu C, Fukushi K, Takei M, et al. Noninvasive and quantitative assessment of the function of multidrug resistance-associated protein 1 in the living brain. J Cereb Blood Flow Metab. 2009;29:504–11.PubMedCrossRef Okamura T, Kikuchi T, Okada M, Toramatsu C, Fukushi K, Takei M, et al. Noninvasive and quantitative assessment of the function of multidrug resistance-associated protein 1 in the living brain. J Cereb Blood Flow Metab. 2009;29:504–11.PubMedCrossRef
29.
go back to reference Ametamey SM, Kessler LJ, Honer M, Wyss MT, Buck A, Hintermann S, et al. Radiosynthesis and preclinical evaluation of 11C-ABP688 as a probe for imaging the metabotropic glutamate receptor subtype 5. J Nucl Med. 2006;47:698–705.PubMed Ametamey SM, Kessler LJ, Honer M, Wyss MT, Buck A, Hintermann S, et al. Radiosynthesis and preclinical evaluation of 11C-ABP688 as a probe for imaging the metabotropic glutamate receptor subtype 5. J Nucl Med. 2006;47:698–705.PubMed
30.
go back to reference DeLorenzo C, Milak MS, Brennan KG, Kumar JSD, Mann JJ, Parsey RV. In vivo positron emission tomography imaging with [11C]ABP688: binding variability and specificity for the metabotropic glutamate receptor subtype 5 in baboons. Eur J Nucl Med Mol Imaging. 2011;38:1083–94.PubMedCrossRef DeLorenzo C, Milak MS, Brennan KG, Kumar JSD, Mann JJ, Parsey RV. In vivo positron emission tomography imaging with [11C]ABP688: binding variability and specificity for the metabotropic glutamate receptor subtype 5 in baboons. Eur J Nucl Med Mol Imaging. 2011;38:1083–94.PubMedCrossRef
31.
go back to reference Ametamey SM, Treyer V, Streffer J, Wys MT, Schmidt M, Blagoev M, et al. Human PET studies of metabotropic glutamate receptor subtype 5 with 11C-ABP688. J Nucl Med. 2007;48:247–52.PubMed Ametamey SM, Treyer V, Streffer J, Wys MT, Schmidt M, Blagoev M, et al. Human PET studies of metabotropic glutamate receptor subtype 5 with 11C-ABP688. J Nucl Med. 2007;48:247–52.PubMed
Metadata
Title
Synthesis and characterization in monkey of [11C]SP203 as a radioligand for imaging brain metabotropic glutamate 5 receptors
Authors
Fabrice G. Siméon
Jeih-San Liow
Yi Zhang
Jinsoo Hong
Robert L. Gladding
Sami S. Zoghbi
Robert B. Innis
Victor W. Pike
Publication date
01-12-2012
Publisher
Springer-Verlag
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 12/2012
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-012-2205-x

Other articles of this Issue 12/2012

European Journal of Nuclear Medicine and Molecular Imaging 12/2012 Go to the issue